MITA Calls for Strengthened Enforcement of Medical Device Remanufacturing

The Medical Imaging & Technology Alliance (MITA) has written a letter that calls for the U.S. Food and Drug Administration’s (FDA) to strengthen its guidance on medical device remanufacturing and urged the agency to take the necessary steps to properly enforce the...

Perlin Named President of The Joint Commission

The Board of Commissioners of The Joint Commission have announced the appointment of Dr. Jonathan B. Perlin to lead The Joint Commission as its next President and CEO. The appointment is effective March 1, 2022. Widely known for his leadership in healthcare quality...

GE Healthcare Introduces New CT System

GE Healthcare has unveiled Revolution Ascend[i] with Effortless Workflow, offering clinicians a collection of artificial intelligence technologies that automate and simplify time-consuming tasks to increase operational efficiency and free up time for clinicians to...

United Imaging uCT ATLAS Earns FDA Clearance

United Imaging has announced FDA clearance for the uCT ATLAS, the latest in the company’s computed tomography (CT) portfolio of scanners and the 25th FDA clearance for the company overall.

SyntheticMR and Philips Ink Agreement


SyntheticMR has entered an agreement with Philips to include SyntheticMR’s medical imaging solution in its global product catalogue. The agreement means that SyntheticMR’s solution SyMRI NEURO will be included in Philips’ third-party product catalogue and enables Philips to offer the complete package to its customers.

SyntheticMR’s software solution for MR imaging, SyMRI NEURO, enables more efficient workflows and supports more precise diagnosis of patients. Philips currently offers the quantitative MR sequence SyntAc as an option to its customers, which in combination with SyntheticMR’s software solution generates multiple contrast-weighted images and volumetric measurements of brain tissue in a single 5-6 minute scan. With this new agreement in place, Philips will now have a streamlined path to provide the complete package SyntAc and SyMRI NEURO to its customers. SyMRI NEURO is already sold by Philips in the U.S. under a regional sales agreement. SyMRI NEURO is compatible with most Philips MRI scanners.

“Philips is an important partner to SyntheticMR and we have established a close collaboration since the first co-marketing agreement was signed in 2015,” says Ulrik Harrysson, CEO, SyntheticMR AB. “We believe this collaboration will greatly benefit clinicians by giving them easy access to a solution that can further enhance their efficiency, diagnostic confidence and monitoring of patients.”

For more information, visit



Submit a Comment

Your email address will not be published. Required fields are marked *